Gastroenterology
Volume 130, Issue 3 , Pages 678-686 , March 2006

Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load

  • Uchenna H. Iloeje

      Affiliations

    • Global Epidemiology and Outcomes Research, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, (Wallingford, Connecticut)
    • ,
  • Hwai–I. Yang

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • Jun Su

      Affiliations

    • Global Epidemiology and Outcomes Research, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, (Wallingford, Connecticut)
    • ,
  • Chin–Lan Jen

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • San–Lin You

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • Chien–Jen Chen

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Genomics Research Center, Academia Sinica, Taipei, Taiwan
    • Corresponding Author InformationAddress requests for reprints to: Professor Chien–Jen Chen, Genomics Research Center, Academia Sinica, 128 Academia Rd, Section 2, Nankang, Tapei 115, Taiwan; fax: (886) 2-23938683.
    • ,
  • The Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group

Received 27 April 2005 ,Accepted 9 November 2005.

References 

  1. Lok AS , Heathcote EJ , Hoofnagle JH . Management of hepatitis B (2000—summary of a workshop) . Gastroenterology . 2001;120:1828–1853
  2. Lee WM . Hepatitis B virus infection . N Engl J Med . 1997;337:1733–1745
  3. Beasley RP . Hepatitis B virus—the major etiology of hepatocellular carcinoma . Cancer . 1988;61:1942–1956
  4. Lok AS , McMahon BJ . Chronic hepatitis B . Hepatology . 2001;34:1225–1241
  5. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B . Hepatology . 2002;35:1522–1527
  6. Fattovich G, Brollo L, Guistina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B . Gut . 1991;32:294–298
  7. Huo T, Wu JC, Hwang SJ, Lai CR, Lee PC, Tsay SH, et al. Factors predictive of liver cirrhosis in patients with chronic hepatitis B (a multivariate analysis in a longitudinal study) . Eur J Gastroenterol Hepatol . 2000;12:687–693
  8. Lin SM , Sheen IS , Chien RN , Chu CM , Liaw YF . Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection . Hepatology . 1999;29:971–975
  9. Liaw YF , Tai DI , Chu CM , Chen TJ . The development of cirrhosis in patients with chronic type B hepatitis (a prospective study) . Hepatology . 1988;8:493–496
  10. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers . Am J Epidemiol . 1997;145:1039–1047
  11. Tamura I, Kurimura O, Koda T, Ichimura H, Katayama S, Kurimura T, et al. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection (a study from Kure, Japan) . J Gastroenterol Hepatol . 1993;8:433–436
  12. Realdi G, Fattovich G, Hadziyannis S, Schalm SW, Almasio P, Tapias J, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B (a multicenter study) . J Hepatol . 1994;21:656–666
  13. Fattovich G , Pantalena M , Zagni I , Realdi G , Schalm SW , Christensen E  European Concerted Action on Viral Hepatitis (EUROHEP) . Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis (a cohort study of 297 patients) . Am J Gastroenterol . 2002;97:2886–2895
  14. Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP study group on Hepatitis B virus and cirrhosis . Hepatology . 1995;21:77–82
  15. de Jongh FE , Janssen HL , de Man RA , Hop WC , Schalm SW , van Blankenstein M . Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver . Gastroenterology . 1992;103:1630–1635
  16. Andreone P, Gramenzi A, Cursaro C, Biselli M, Camma C, Trevisani F, et al. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance . J Viral Hepat . 2004;11:439–442
  17. Fattovich G , Guistina G , Realdi G , Corrocher R , Schalm SW . Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa . Hepatology . 1997;26:1338–1342
  18. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee C-Z, Yuen H, et al  Lamivudine for patients with chronic hepatitis B and advanced liver disease . N Engl J Med . 2004;351:1521–1531
  19. Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B . N Engl J Med . 1996;334:1422–1427
  20. Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio P, et al. Clinical outcomes of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine . Hepatology . 2004;40:883–891
  21. Lin DY , Sheen IS , Chiu CT , Lin SM , Kuo YC , Liaw YF . Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B (a longitudinal study) . J Clin Ultrasound . 1993;21:303–308
  22. Nelson W . Theory and applications of hazard plotting for censored failure data . Technometrics . 1972;14:945–965
  23. Breslow N , Crowley J . A large sample study of the life table and product limit estimates under random censorship . Ann Statist . 1974;2:437–453
  24. Aalen O . Nonparametric inference for a family of counting processes . Ann Statist . 1978;6:701–726
  25. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma (a prospective study in men) . J Natl Cancer Inst . 2005;97:265–272
  26. McMahon BJ , Holck P , Bulkow L , Snowball M . Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus . Ann Intern Med . 2001;135:759–768
  27. McMahon BJ , Alberta SR , Wainwright RB , Bulkow L , Lanier AP . Hepatitis B–related sequelae—prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers . Arch Intern Med . 1990;150:1051–1054
  28. Nakamoto Y , Guidotti LG , Kuhlen CV , Fowler P , Chisari FV . Immune pathogenesis of hepatocellular carcinoma . J Exp Med . 1998;188:341–350
  29. Yuen MF , Lai CL . Towards control of hepatitis B in the Asia-Pacific region—natural history of chronic hepatitis B virus infection . J Gastroenterol Hepatol . 2000;15:E20–E24
  30. Maruyama T , Iino S , Koike K , Yasuda K , Milich DR . Serology of acute exacerbation in chronic hepatitis B virus infection . Gastroenterology . 1993;105:1141–1151
  31. Liaw YF , Pao CC , Chu CM , Sheen IS , Huang MJ . Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis . Hepatology . 1987;7:1–3
  32. Moreno-Otero R , Garcia-Monzon C , Garcia-Sanchez A , Buey L , Pajares JM , Di Bisceglie AM . Development of cirrhosis after chronic type B hepatitis (a clinicopathologic and follow-up study of 46 HBeAg-positive asymptomatic patients) . Am J Gastroenterol . 1991;86:560–564
  33. Zhou X , Gao Z , Yao J . Relationship between HBV DNA serum level and acute exacerbation of the disease in chronic hepatitis B patients . Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi . 1999;13:335–339
  34. Liaw YF , Chu CM , Lin DY , Sheen IS , Yang CY , Huang MJ . Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan (a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma) . J Med Virol . 1984;13:385–391
  35. Hung CH, Lu SN, Wang JH, Lee CM, Chen TM, Tung HD, et al. Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis . J Gastroenterol . 2003;38:153–157
  36. Iwao T, Toyonaga A, Tayama C, Masumoto H, Sakai T, Sato M, et al. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension . K O, Am J Gastroenterol . 1997;92:1012–1017
  37. Gaiani S, Gramantieri L, Venturoli N, Piscaglia F, Siringo S, D’Errico A, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy . J Hepatol . 1997;27:979–985
  38. Nishiura T, Watanabe H, Ito M, Matsuoka Y, Yano K, Daikoku M, et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes . Br J Radiol . 2005;78:189–197
  39. Sanford NL , Walsh P , Matis C , Baddeley H , Powell LW . Is ultrasonography useful in the assessment of diffuse parenchymal liver disease . Gastroenterology . 1985;89:186–191
  40. Celle G , Savarino V , Picciotto A , Magnolia MR , Scalabrini P , Dodero M . Is hepatic ultrasound a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques . Dig Dis Sci . 1988;33:467–471
  41. Lok AS , McMahon BJ . Chronic hepatitis B (update of recommendations) . Hepatology . 2004;39:857–861
  42. Kao JH , Chen PJ , Lai MY , Chen DS . Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B . Gastroenterology . 2000;118:554–559
  43. Kao JH , Chen PJ , Lai MY , Chen DS . Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection . J Clin Microbiol . 2002;40:1207–1209

 Supported by a grant from the Department of Health, Executive Yuan, Taipei, Taiwan, and by a grant from Bristol-Myers Squibb Company.

PII: S0016-5085(05)02276-6

doi: 10.1053/j.gastro.2005.11.016

Gastroenterology
Volume 130, Issue 3 , Pages 678-686 , March 2006

Article Tools

* Image Usage & Resolution